In fact, the ability of AnxA1 to stimulate endogenous pro-resolving pathways leading to tissue repair and healing and its therapeutic effects have been documented in a broad range of experimental models, including myocardial ischemia injury, stroke, sepsis, arthritis, and multiple sclerosis12. Here, ANXA1 is linked to arthritic joint disease.